Name: The Oncology Institute, Inc. (TOI) Balance Sheet
Creator: FinSpry

The Oncology Institute Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for The Oncology Institute, Inc. (TOI) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	49.67	49.37	14.01	114.30	6.00
Short-Term Investments	0.00	49.37	59.80	0.00	0.00
Cash & Short-Term Investments	49.67	49.37	73.81	114.30	6.00
Accounts Receivable	48.68	42.91	40.43	21.24	17.26
Inventory	10.04	13.68	9.26	6.44	4.35
Other Current Assets	4.03	0.29	6.92	0.10	2.11
Total Current Assets	112.42	143.49	130.42	154.06	29.72
Non-Current Assets
Property, Plant & Equipment (Net)	37.67	40.05	33.04	4.19	2.10
Long-Term Investments	0.00	0.00	58.35	0.00	0.00
Goodwill	7.23	7.23	21.42	26.63	14.23
Intangible Assets	14.81	17.90	17.96	18.25	19.52
Other Non-Current Assets	0.59	0.56	0.48	0.32	0.12
Total Non-Current Assets	60.30	65.75	131.25	49.38	0.00
Total Assets	172.72	209.24	261.67	203.44	65.69
Current Liabilities
Accounts Payable	24.32	28.43	9.37	29.62	12.64
Short-Term Debt	6.80	0.00	0.00	0.18	5.37
Current Portion of Long-Term Debt	0.00	0.00	0.00	0.18	5.37
Accrued Liabilities	12.98	5.18	9.42	5.01	4.21
Deferred Revenue	4.70	1.09	1.14	0.59	3.38
Other Current Liabilities	3.38	14.00	4.04	13.92	1.86
Total Current Liabilities	52.22	34.79	29.72	29.80	28.61
Non-Current Liabilities
Long-Term Debt	93.13	113.31	80.62	0.00	6.56
Deferred Tax Liabilities	0.03	0.03	0.11	0.37	1.61
Other Non-Current Liabilities	0.46	1.00	5.98	6.90	0.81
Total Non-Current Liabilities	116.91	117.43	108.77	9.46	0.00
Total Liabilities	169.13	152.22	138.49	99.28	37.59
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.01
Retained Earnings	-210.81	-146.15	-63.08	-63.23	-52.31
Treasury Stock	1.02	-1.02	0.00	0.00	0.00
Additional Paid-in Capital	215.41	204.19	186.25	167.39	0.00
Shares Outstanding	75.74	74.15	73.27	73.25	0.00
Total Stockholders' Equity	3.59	57.03	123.18	104.16	28.10
Total Liabilities & Equity	172.72	209.24	261.67	203.44	0.00